Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?
Author
Ornek, S.
Engin, B.
Can, P.
Hasal, E.
Atakan, N.
Kocaturk, E.
Baskan, E. B.
Ozdemir, M.
Kucuk, O. S.
Metadata
Show full item recordCollections
- Bildiri [64839]